(Q41049547)

26 September 2017

Acute phase reactants. II. Serum hexosamines in patients with rheumatic fever and related diseases (English)

1 reference

26 September 2017

0 references

KELLEY VC

1

1 reference

PubMed ID

14918031

26 September 2017

language of work or name

English

0 references

publication date

1 April 1952

1 reference

The Journal of Pediatrics

26 September 2017

1 reference

26 September 2017

40

1 reference

26 September 2017

4

1 reference

26 September 2017

413-422

1 reference

THE CONCENTRATION OF GLUCOSAMINE IN NORMAL AND PATHOLOGICAL SERA.

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2852%2980204-5

Plasma hexosamine levels in acute rheumatic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2852%2980204-5

The effect of adrenocorticotropic hormone and cortisone on the serum hexosamine level in acute disseminated lupus erythematosus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2852%2980204-5

Serum polysaccharide level in the normal state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2852%2980204-5

A colorimetric method for the determination of glucosamine and chondrosamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2852%2980204-5

STUDIES ON THE MUCOPROTEINS OF HUMAN PLASMA. I. DETERMINATION AND ISOLATION.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2852%2980204-5

Metabolism of Hyaluronic Acid in Relation to Rheumatic Diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2852%2980204-5

The pathogenesis of lupus erythematosus and allied conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2852%2980204-5

THE ROLE OF THE MUCOID POLYSACCHARIDE (HYALURONIC ACID) IN THE VIRULENCE OF GROUP A HEMOLYTIC STREPTOCOCCI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2852%2980204-5

THE EFFECT OF EXTRACTS OF CERTAIN ORGANS FROM NORMAL AND IMMUNIZED ANIMALS ON THE INFECTING POWER OF VACCINE VIRUS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2852%2980204-5

STUDIES ON A CERTAIN SPREADING FACTOR EXISTING IN BACTERIA AND ITS SIGNIFICANCE FOR BACTERIAL INVASIVENESS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2852%2980204-5

A SPREADING FACTOR IN CERTAIN SNAKE VENOMS AND ITS RELATION TO THEIR MODE OF ACTION.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2852%2980204-5

THE INFLUENCE OF TESTICLE EXTRACT ON THE INTRADERMAL SPREAD OF INJECTED FLUIDS AND PARTICLES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2852%2980204-5

Studies on diffusing factors. Active preparations from mammalian testicle and their biological assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2852%2980204-5

Studies on diffusing factors: The hyaluronidase activity of testicular extracts, bacterial culture filtrates and other agents that increase tissue permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2852%2980204-5

The biological significance of hyaluronic acid and hyaluronidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2852%2980204-5

HYALURONIDASES OF BACTERIAL AND ANIMAL ORIGIN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2852%2980204-5

On the occurrence in human serum of an inhibitory substance to hyaluronidase produced by a strain of hemolytic streptococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2852%2980204-5

ANTIHYALURONIDASE STUDIES OF SERA FROM PATIENTS WITH RHEUMATIC FEVER, STREPTOCOCCAL INFECTIONS, AND MISCELLANEOUS NON-STREPTOCOCCAL DISEASES.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2852%2980204-5

Hyaluronidase inhibitors in body fluids in normal and disease states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2852%2980204-5

Mucolytic enzyme systems; inhibition of hyaluronidase by serum in infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2852%2980204-5

Mucolytic enzyme systems; nonspecific hyaluronidase inhibitor in rheumatic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2852%2980204-5

Mucolytic enzyme systems. XI. Hyaluronidase inhibitor and serum mucoproteins in patients with lipoid nephrosis and acute glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2852%2980204-5

Influence of hyaluronidase and steroids on permeability of synovial membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2852%2980204-5

10.1016/S0022-3476(52)80204-5

7 January 2021

Identifiers

DOI

1 reference

26 September 2017

1 reference

PubMed ID

14918031